You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
衞光生物(002880.SZ):擬與衞光生命科技控股、深圳方略資本等等設衞光瑞康
格隆匯 09-23 19:18

格隆匯9月23日丨衞光生物(002880.SZ)公佈,公司為優化科研成果分配體系,加速創新項目研究和技術成果轉化,激發研發人員的工作熱情和創新活力,加快創新項目研發進度出資510深圳市衞光生命科技控股集團有限公司深圳方略資本管理有限公司或其指定出資方深圳市同管理諮詢合夥企業(有限合夥)(益管理)共同投資設立深圳市衞光瑞康生物科技有限公司(暫定名,以工商行政管理部門最終核准結果為準光瑞康)

投資設立控股子公司可通過升級經營結構,實施多元化管控,形成富有活力和競爭力的市場化經營機制;同時通過科研人員和核心員工出資跟投參股、引入社會資本的方式減輕上市公司研發支出負擔,符合公司戰略發展目標。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account